Back

Is the polypill effective in secondary prevention? The evidence.

7 April 2017 (17:15 - 17:37)
Organised by:
Congress Presentation Part of: The cardiovascular polypill: practical implementation Miscellaneous Open Access EuroPrevent 2017

About the speaker

Photo
Professor Vivencio Barrios

Ramon and Cajal University Hospital, Madrid (Spain)

3 More presentations in this session

Presentation thumbnail
Rationale for the use of the polypill in cardiovascular disease.
Professor D. Grobbee (Utrecht, NL)
Slides Video
Presentation thumbnail
Is the polypill effective in primary prevention? The evidence.
Doctor M. Lafeber (Utrecht, NL)
Slides Video
Presentation thumbnail
Practical implementation of the polypill, current status and future challenges.
Professor J. Gonzalez Juanatey (Santiago de Compostela, ES)
Slides Video

Access the full session

Session thumbnail
The cardiovascular polypill: practical implementation

The Event

Event poster

EuroPrevent 2017

7 April 2017 17:15 CET
You may be interested in
thumbnail
Congress Presentation
Polypill to improve adherence in cardiovascular secondary prevention: a real challenge in real practice
3 September 2019
thumbnail
Webinar
Reducing risk in the post-MI patient
6 September 2023
thumbnail
Congress Presentation
Stroke
26 August 2023
thumbnail
Congress Presentation
Secondary prevention in young patients after acute ST segment elevation myocardial infarction: missing the goals and suffering the penalties
26 April 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources